Representative Lisa C. McClain (R-Michigan) recently sold shares of Waters Corporation NYSE: WAT. In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Waters stock on July 22nd. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
- Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Apple NASDAQ: AAPL on 7/22/2025.
Waters Price Performance
Shares of WAT stock traded up $8.3620 during trading hours on Tuesday, reaching $297.7620. The company's stock had a trading volume of 645,955 shares, compared to its average volume of 616,625. The firm's 50 day simple moving average is $318.27 and its 200-day simple moving average is $344.80. The company has a market capitalization of $17.72 billion, a price-to-earnings ratio of 26.85, a PEG ratio of 2.72 and a beta of 1.04. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55.
Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. The firm had revenue of $771.33 million for the quarter, compared to the consensus estimate of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company's revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business posted $2.63 EPS. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts forecast that Waters Corporation will post 12.86 earnings per share for the current year.
Analysts Set New Price Targets
WAT has been the topic of several recent research reports. Wall Street Zen downgraded Waters from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the company a "hold" rating in a report on Tuesday, August 5th. Scotiabank reiterated a "sector outperform" rating and issued a $465.00 price target on shares of Waters in a research report on Friday, July 11th. Robert W. Baird reduced their price target on Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 16th. Finally, UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Waters presently has a consensus rating of "Hold" and a consensus target price of $378.73.
Read Our Latest Research Report on Waters
Hedge Funds Weigh In On Waters
Several institutional investors have recently modified their holdings of the business. Brighton Jones LLC grew its holdings in Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier's stock valued at $471,000 after purchasing an additional 673 shares during the period. Federated Hermes Inc. raised its position in shares of Waters by 29.2% in the fourth quarter. Federated Hermes Inc. now owns 270 shares of the medical instruments supplier's stock worth $100,000 after buying an additional 61 shares in the last quarter. Cerity Partners LLC increased its stake in Waters by 11.5% in the fourth quarter. Cerity Partners LLC now owns 5,962 shares of the medical instruments supplier's stock valued at $2,187,000 after acquiring an additional 613 shares during the last quarter. Raymond James Financial Inc. bought a new position in Waters in the fourth quarter valued at $40,404,000. Finally, Sterling Capital Management LLC grew its stake in shares of Waters by 27.0% during the fourth quarter. Sterling Capital Management LLC now owns 1,944 shares of the medical instruments supplier's stock valued at $721,000 after buying an additional 413 shares during the last quarter. 94.01% of the stock is owned by institutional investors.
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
Waters Company Profile
(
Get Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.